RepliCel Life Sciences (TSXV: RP) CEO: We’re Excited About This Year’s Developments

RepliCel Life Sciences Inc. (TSXV: RP) President and CEO Lee Buckler talks with SmallCapPower about this regenerative medicine company that is focused on developing cell therapies for the treatment of aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. Find out what new developments RepliCel Life Sciences has planned for 2017…